IL37 and atopic eczema: A recent report finds that IL-37 ameliorates local inflammation in atopic dermatitis by regulating gut microbiota through the AMPK-mTOR signaling pathway (32), further supporting the concept that IL-37 may act on both local and systemic responses via manipulating intestinal mucosal microbiota, an idea that requires further investigation.